Skip to main content
. Author manuscript; available in PMC: 2012 Nov 21.
Published in final edited form as: Stat Commun Infect Dis. 2011 Oct;3(1):1037. doi: 10.2202/1948-4690.1037

Figure 1.

Figure 1

P = 0.6 non-efficacy boundary comparing a vaccine regimen versus placebo, for the scenario where the first interim analysis occurs at n1=75 infections diagnosed within 18 months. If the final analysis at nmax infections is reached before the boundary is crossed, then the reported 95% confidence interval for VE(0-18) will be above 0%.